Trademarkia Logo

Canada

C$
Trademark Search in Canada
BY PATIENTS, FOR PATIENTS

View On IC.GC.CA

BY PATIENTS, FOR PATIENTS
ADVERTISED

on 2 Apr 2025

Last Applicant/ Owned by

REFLECTION BIOTECHNOLOGIES LIMITED

Unit 601, 6/F, Core Building 1No. 1 Science Park E. Ave., Pak Shek KokNew Territories,

HK

Serial Number

1992299 filed on 24th Oct 2019

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

BY PATIENTS, FOR PATIENTS

Trademark usage description

pharmaceuticals, medical and veterinary preparations for genetically based diseases and rare disorders, namely, pharmaceutical preparations for the tr Read More

Classification Information

Class [005]
Pharmaceuticals, medical and veterinary preparations for genetically based diseases and rare disorders, namely, pharmaceutical preparations for the treatment of neurological disorders and ocular diseases; dietetic food and substances, in the nature of sugar adapted for medical or veterinary use, food for babies; medical plasters; material for stopping teeth, dental wax; preparations for destroying vermin; fungicides, herbicides; medicines for human purposes for the treatment of genetically based diseases and rare disorders, namely, neurological disorders and ocular diseases; pharmaceutical preparations for gene therapy and cell therapy

Classification kind code

11

Class [035]
Advertising, marketing, promotional and business

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [036]
Actuarial services; providing financial management information via a website; financial research and financial management information services; financial management; insurance services, namely, underwriting and brokerage of health, medical, and life insurance; insurance brokerage; insurance underwriting; providing rebates at participating establishments of others through use of a membership card; insurance information and consultancy services; real estate services, namely, real estate management and investment services; financial affairs and monetary affairs, namely, financial planning information, management and analysis services; financial management consultancy services; capital investment services; financial customs brokerage services; financial evaluations for insurance purposes; investment of funds; fiscal valuation; charitable fundraising; charitable foundation services, namely, organizing fundraising activities for a charitable organization; financial sponsorship of patients and families for payment of healthcare, medical, and insurance bills; financial sponsorship of scientific, medical, and drug research and development; financial sponsorship of projects promoting awareness and knowledge of diseases and healthcare issues and facilitating patient, doctor, and healthcare networks

Classification kind code

11

Class [038]
Telecommunications

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [042]
Scientific and technological services and research and design in the fields of genetically based diseases and rare disorders, orphan drugs, gene therapy, and cell therapy; industrial analysis and research services in the fields of genetically based diseases and rare disorders, orphan drugs, gene therapy, and cell therapy; design and development of computer hardware and software; scientific and medical research and development; research and development of orphan drugs

Classification kind code

11

Class [044]
Medical services, namely gene therapy and cell therapy services; veterinary services; horticulture services; agricultural services, namely, compost spreading; forestry services, namely, insecticide spraying for forestry; health and medical counselling, namely, advisory and consultancy services for patients in the field of patient access to medical treatment services; providing health care and medical information in the field of patient access to medical treatment services; Providing a disease or patient forum or patient registry featuring medical and educational information regarding genetically based diseases, rare diseases, orphan drugs, gene therapy, cell therapy, precision medicine and other treatment options, disease diagnosis, clinical and research networks, and medical service providers, insurance companies, hospitals and others involved in medical care via a website, mobile software application, social media account, computers, and online computer databases; Personal and social services rendered by others to meet the needs of individuals, namely, providing patient advisory and information services regarding the coordination and combination of efforts by patients and families in driving scientific and medical research and development; Health care advisory and information services for patients and their families regarding the coordination of medical services; Advice and consultation services, namely, providing advice, information and assistance to patients and their families in dealing with medical service providers, hospitals, insurance companies, and others involved in patient care; personal and social services rendered by others to meet the needs of individuals, namely, providing patient advocacy services in the field of coordination and combination of efforts by patients and families to improve access to medical treatment services; providing patient advocacy services in the field of gene therapy and cell therapy; providing case management services, namely, coordinating patient and family health care medical services; health care advocacy services for patients and their families regarding the coordination of medical services; health care case management advice and consultation services, namely, medical care coordination for patients and families

Classification kind code

11

Class [045]
Personal and legal

Comment text

CIPO Classification Code

Classification kind code

Nice

Mark Details

Serial Number

1992299

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 42
on 2th Apr 2025		Advertised
Submitted for opposition 26
on 3rd Mar 2025		Approved
Submitted for opposition 27
on 3rd Mar 2025		Approval Notice Sent
Submitted for opposition 22
on 6th Jun 2024		Search Recorded
Submitted for opposition 20
on 6th Jun 2024		Examiner's First Report
Submitted for opposition 287
on 15th Jun 2022		Pre-Assessment Letter Sent
Submitted for opposition 31
on 21st Nov 2019		Formalized
Submitted for opposition 1
on 25th Oct 2019		Created
Submitted for opposition 30
on 24th Oct 2019		Filed